Christine Guo

Featured in: Favicon

cell.com

morningstar.com Favicon

streetinsider.com Favicon

advfn.com

medcitynews.com Favicon

endpts.com Favicon

clinicalleader.com Favicon

appliedclinicaltrialsonline.com Favicon

investorsobserver.com Favicon

theblockchaindomain.io

Articles

Redefining Clinical Development of Obesity Drugs: What Does Success Look Like? - MedCity News

Nov 3, 2024 | medcitynews.com | Christine Guo |Eve McDavid |Stephanie Baum

Nearly seven years after the FDA approved Novo Nordisk’s Ozempic for diabetes treatment, this medication and other GLP-1 receptor agonists have proven very effective in promoting weight loss. For the millions struggling with obesity, they offer a way to reduce appetite, manage blood sugar levels, lose weight, and decrease the risk of the comorbidities associated with having a higher body mass. The has warned that by 2035 approximately 4.4 billion people globally will be classified as obese.
07.01.24 -- Effective Feasibility Strategies For Research-Naïve Sites

Jul 1, 2024 | clinicalleader.com | Dan Schell |Christine Guo |Kamila Novak

Webinar: Building One Home for Sites – The only industry-wide solution to site tech overloadPharmaceutical companies have asked clinical research sites to use more and more technology to execute the trials they sponsor leading to site tech overload. Join us in this webinar to discover what can be done to take away the burden on sites and still gain the benefits being delivered by clinical technology innovators. Click here to learn more.
06.25.24 -- The Future Of Epilepsy Research And Transformative Treatments

Jun 25, 2024 | clinicalleader.com | Mike Davis |Kevin Landells |Christine Guo |Chris Manchester

CLINICAL TRIAL TECHNOLOGYThe Future Of Epilepsy Research And Transformative TreatmentsUCB's Head of Epilepsy and Rare Syndromes discusses the future of epilepsy treatment and clinical trials. Using Tech Enabled Solutions To Boost Productivity And SustainabilityTrials continue to face challenges related to cost, patient tech adoption, and resource management. Uncover how investing in tech solutions can enhance efficiency and reduce companies' carbon footprint.
The Meaningful Aspect Of Health That's Overlooked In Clinical Trials

Jun 17, 2024 | clinicalleader.com | Christine Guo

By Christine Guo Sleep is a intricate and multifaceted biological process crucial for human survival, increasingly linked through research to a range of adverse health outcomes. Sleep deficiency has been associated with heightened risks of cardiovascular diseases, metabolic disorders, cancer, compromised immune function, mood disorders, neurodegenerative conditions, accidents, and social isolation.
Zulu Network Secures $3 Million in Pre-Seed Funding to Revolutionize Bitcoin Layer 2

Apr 5, 2024 | morningstar.com | Christine Guo

George Town, Cayman Islands, April 05, 2024 (GLOBE NEWSWIRE) -- In a landmark move for the Bitcoin Economy, Zulu Network, the first Two-Tiered Bitcoin Layer 2 offering EVM and UTXO support, has successfully closed $3 million in pre-seed funding, marking a significant milestone in reshaping the Bitcoin ecosystem.
Perspective on the Fda’s Final Digital Health Technologies Guidance

Jan 24, 2024 | clinicalleader.com | Christine Guo

Article | January 24, 2024 By Christine Guo, Ph.D. The landscape of clinical research and healthcare is significantly shaped by regulatory guidance, and last month marked a milestone with the release of the FDA guidance titled "Digital Health Technologies for Remote Data Acquisition in Clinical Investigations." This culmination follows a decade of exploration with wearable sensors in industry research and decades of application in academic research.
Position Your DHT Innovation For Success

Dec 8, 2023 | clinicalleader.com | Christine Guo

Article | December 8, 2023 By Christine Guo, PhD Clinical trialists of today stand to gain valuable insights from the hard-earned lessons accumulated over the past decade. Individuals new to this field often concentrate on the aesthetics and functionalities of wearable devices, drawing parallels with their consumer experiences.
Why Wearable DHTs are Bringing More Meaningful Data Collection to Patient-Centric Clinical Trials

Nov 7, 2023 | appliedclinicaltrialsonline.com | Christine Guo

Published on: Wearable digital health technologies can enhance traditional clinical outcome assessments, such as for neurology, pulmonology, cardiology, and rheumatology. In the intricate landscape of clinical development, proving the efficacy of medical interventions based on clinical outcome assessments (COAs) has long stood out as a complex and costly task. These assessments, vital for gauging the success of new treatments, have been a cornerstone of the research process for decades.
Paving The Way For Virtual Trials In Neurology: A Fully Remote ALS Study

May 23, 2023 | clinicalleader.com | Christine Guo

By Christine Guo, ActiGraph Chief Scientific Officer The COVID-19 pandemic has completely changed the way we think about clinical research and care. Clinical trials, a vital component of the drug development process, were heavily disrupted because patients, often with weakened immune systems, could not visit hospitals and research sites.